Official UK visa sponsor profile for Depixus in CAMBRIDGE, including current register status, route details, and public company data.
Depixus | Reg: FC032917 | Created: 2015-11-12 | Status: active | Type: international-company Depixus is a global leader in magnetic force spectroscopy (MFS) technology, specializing in the development and commercialization of innovative analytical solutions. Established in 2015, the company focuses on providing rapid, high-throughput analysis of biomolecular interactions, primarily within the pharmaceutical and biotechnology industries. Depixus MAGNA One represents a core technology platform designed for the analysis of thousands of biomolecular interactions within a single sample. This technology offers significant advantages over traditional methods, including increased throughput, improved sensitivity, and reduced sample volume requirements. The system facilitates real-time monitoring of critical events in drug discovery and development processes. Depixus operates internationally, with a significant presence in Europe and North America. The company’s core business centers around providing MFS solutions to pharmaceutical companies, research institutions, and contract research organizations. The company’s workforce includes highly skilled scientists and engineers dedicated to innovation and technological advancement. Key industry focuses include pharmaceuticals, biotechnology, and diagnostics. Depixus’s international reach and technological expertise position it as a key provider of analytical tools for accelerating scientific breakthroughs.
Official UK visa sponsor profile for Depixus in CAMBRIDGE, including current register status, route details, and public company data.
Depixus | Reg: FC032917 | Created: 2015-11-12 | Status: active | Type: international-company Depixus is a global leader in magnetic force spectroscopy (MFS) technology, specializing in the development and commercialization of innovative analytical solutions. Established in 2015, the company focuses on providing rapid, high-throughput analysis of biomolecular interactions, primarily within the pharmaceutical and biotechnology industries. Depixus MAGNA One represents a core technology platform designed for the analysis of thousands of biomolecular interactions within a single sample. This technology offers significant advantages over traditional methods, including increased throughput, improved sensitivity, and reduced sample volume requirements. The system facilitates real-time monitoring of critical events in drug discovery and development processes. Depixus operates internationally, with a significant presence in Europe and North America. The company’s core business centers around providing MFS solutions to pharmaceutical companies, research institutions, and contract research organizations. The company’s workforce includes highly skilled scientists and engineers dedicated to innovation and technological advancement. Key industry focuses include pharmaceuticals, biotechnology, and diagnostics. Depixus’s international reach and technological expertise position it as a key provider of analytical tools for accelerating scientific breakthroughs.
Yes, Depixus is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Industry classification information is currently being updated for this sponsor.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Depixus is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Industry classification information is currently being updated for this sponsor.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.